## 

## 

## 

## 



## 

## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

||Notes|Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|
|||Funds|Funds|Funds|Funds|
|||2021-22f|2021-22f|2021-22f|2020-21<br>f|
|Income||||||
|Charitable activities||||||
|Course income||30,250||30,250|21,575|
|Other income||330||330|340|
|Total Income||30,580||30,580|21,915|
|Expenditure||||||
|Charitable<br>activities||||||
|Course expenditure||27,068||27,068|11,280|
|Donations||2,550||2,550|2,600|
|Total||29,618||29,618|13,880|
|Other expenditure||||||
|Support costs||2,926|1,456|4,382|3,567|
|Total Expenditure||32,544|1,456|34,000|17,447|
|Net (Expenditure)/Income||(1,964)|(1,456)|(3,420)|4,468|
|Reconciliation ofFunds||||||
|Total Funds brought forward||75,661|17,384|93,045|88,577|
|Total Funds carried forward||7$,697|15,928|89,625|9$,045|





|||||||2022|2021|
|---|---|---|---|---|---|---|---|
||||Notes|Unrestricted|Restricted|Total|Total|
|||||Funds<br>f|Funds<br>f|Fundsf|Fundsf|
|Current Assets||||||||
|Debtors||||852||852|549|
|Cash at bank and in||||88,496|15,928|104,424|105,396|
|hand||||||||
|||||89,348|15,928|105,276|105,945|
|Creditors:||||||||
|Amounts|falling|||(15,651)||(15,651)|(12,900)|
|due within|one|||||||
|year||||||||
|Net Current||Assets||73,697|15,928|89,625|93,045|
|Funds||||||||
|Unrestricted||Funds||73,697||73,697|75,661|
|Restricted|Funds||||15,928|15,928|17,384|
|TotalFunds||||73,697|15,928|89,625|93,045|





## 

## 

## 

## 

## 

## 



## 


||||||Surplus/|
|---|---|---|---|---|---|
|2021-22|||Income<br>f|Expense<br>f|(Oeficit)f|
|Prostate Sept 2021|||4,600|(3,108)|1,492|
|Bladder Sept 2021|||5,100|(2,608)|2,492|
|Kidney, Testis &Penis Sept 2021|||3,000|(1,955)|1,045|
|BDIAP/BAUP Symposium|Nov|2021||(2,514)|(2,514)|
|Bladder Jan/Feb 2022|||4,000|(1,850)|2,150|
|Prostate Feb 2022|||3,900|(1,850)|2,050|
|Bladder May 2022|||9,650|(13,183)|(3,533)|
|Total for Courses 2021-22|||30,250|(27,068)|3,182|
|Total for Courses 2020-21|||21,575|(11,280)|10,295|
|Other income||||||
||||2021-22|2020-21||
||||f|f||
|Full membership<br>subscriptions|||330|340||
|haritable activities: Donations||||||
||||2021-22|2020-21||
||||f|f||
|Africa Cancer Action Trust|||1,800|2,300||
|The Orchid Cancer Appeal|||750|300||
||||2,550|2,600||
|ther Expenditure:<br>Support costs||||||
||||2021-22|2020-21||
||||f|f||
|Finance: Accounting<br>services|||179|392||
|Bank &PayPal Charges|||769|686||
|Information<br>Technology|||1,267|1,064||
|Other Support Costs|||711|668||
||||2,926|2,810||
|Restricted<br>Funds Expenditure||(Note 11)|1,456|757||
||||4,382|3,567||





## 



## 




|9|Creditors:|Amounts|falling due within one year|||
|---|---|---|---|---|---|
|||||2022f|2021f|
||Deferred|Course Income (Note 10)||14,900|12,900|
||Accruals|||751||
|||||15,651|12,900|





## 

## 

|Deferred|Course income|||
|---|---|---|---|
|||2022|2021|
|||f|f|
|Balance|at 1September|12,900|5,675|
|Amounts|added<br>in period|14,900|12,900|
|Amounts|released to income from|(12,900)|(5,675)|
|previous|periods|||
|Balance|at31August|14,900|12,900|



## 

||2022|2021|
|---|---|---|
|||f|
|Balance at 1September|17,384|18,141|
|EQAexpenditure|(1,456)|(757)|
||15,928|17,384|